Hydrogen Nanobubbles Protect Heart from Chemotherapy Damage

Authors
Journal
ACS Applied Materials & Interfaces
Year
DOI
10.1021/acsami.5c22351
Study Type
Mouse
Outcome
Positive
Peer Reviewed
Yes
Country
China
Health Condition
Chemotherapy-Induced Cardiotoxicity
Body System
Cardiovascular

TL;DR

Hydrogen nanobubbles reduced doxorubicin-induced cardiac injury and fibrosis by lowering oxidative stress and suppressing PI3K/AKT and TGF-β/SMAD signaling in preclinical models.

Key Finding

Hydrogen nanobubbles reduced doxorubicin-induced heart damage in mice by lowering oxidative stress and preventing heart tissue scarring, with improvements visible in heart function tests.

Summary

Researchers created tiny hydrogen-filled particles (about 265 nanometers in size) and tested whether they could protect heart cells from damage caused by doxorubicin, a common chemotherapy drug. In laboratory and mouse studies, these hydrogen nanobubbles reduced harmful molecules called free radicals in heart cells, prevented cell death, and reduced scarring of heart tissue—all while showing good safety. The treatment appeared to work by turning on the heart's natural defense systems and blocking two specific damage pathways in cells.

Practical Takeaway

This is early-stage research conducted only in mice and laboratory cell studies, not yet tested in humans. While the results suggest hydrogen delivery via nanobubbles may have potential to protect heart tissue from chemotherapy damage, it is far too early to draw conclusions about whether this approach would work in people or could be used clinically. Much more research, including human trials, would be needed before any therapeutic application.

Abstract (excerpt)

The most severe side effect of chemotherapy is cardiotoxicity, frequently causing myocardial injury characterized by excessive oxidative stress and fibrosis for which effective treatments are lacking. To address this, a hydrogen delivery system, hydrogen nanobubbles (HNBs), was constructed…

Read the full abstract via DOI